ATE414904T1 - Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo - Google Patents
Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivoInfo
- Publication number
- ATE414904T1 ATE414904T1 AT03794267T AT03794267T ATE414904T1 AT E414904 T1 ATE414904 T1 AT E414904T1 AT 03794267 T AT03794267 T AT 03794267T AT 03794267 T AT03794267 T AT 03794267T AT E414904 T1 ATE414904 T1 AT E414904T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- complex
- glycoprotein
- vivo
- testing
- Prior art date
Links
- 102100030802 Beta-2-glycoprotein 1 Human genes 0.000 title 1
- 108010023562 beta 2-Glycoprotein I Proteins 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000000691 measurement method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Endocrinology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002261366 | 2002-09-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE414904T1 true ATE414904T1 (de) | 2008-12-15 |
Family
ID=31973126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03794267T ATE414904T1 (de) | 2002-09-06 | 2003-09-05 | Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7455976B2 (de) |
| EP (1) | EP1548436B1 (de) |
| JP (1) | JP4280236B2 (de) |
| AT (1) | ATE414904T1 (de) |
| AU (1) | AU2003261976A1 (de) |
| DE (1) | DE60324820D1 (de) |
| WO (1) | WO2004023141A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2728473A1 (en) | 2008-06-20 | 2009-12-23 | National University Corporation Okayama University | Antibody against oxidized ldl/.beta.2gpi complex and use of the same |
| EP2462440B1 (de) * | 2009-08-07 | 2017-05-17 | Astute Medical, Inc. | Verfahren und zusammensetzungen zur diagnose und prognose von nierenverletzungen und niereninsuffizienz |
| JP6399987B2 (ja) * | 2015-09-11 | 2018-10-03 | ヤマサ醤油株式会社 | 抗β２−ＧＰＩ抗体の測定法 |
| US10858422B2 (en) | 2016-05-31 | 2020-12-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
| US10434141B2 (en) | 2016-05-31 | 2019-10-08 | Abcentra, Llc | Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody |
| JP6826740B1 (ja) * | 2020-02-06 | 2021-02-10 | 国立大学法人 岡山大学 | 酸化ＬＤＬ／β２ＧＰＩ複合体の検出方法、及び、検出キット |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07306202A (ja) | 1992-04-01 | 1995-11-21 | Maruzen Petrochem Co Ltd | 細胞核ｄｎａの損傷検出方法 |
| JP3370334B2 (ja) | 1993-09-29 | 2003-01-27 | 栄次 松浦 | 酸化リポタンパク質の測定法およびその用途 |
-
2003
- 2003-09-05 DE DE60324820T patent/DE60324820D1/de not_active Expired - Lifetime
- 2003-09-05 AU AU2003261976A patent/AU2003261976A1/en not_active Abandoned
- 2003-09-05 JP JP2004534180A patent/JP4280236B2/ja not_active Expired - Fee Related
- 2003-09-05 AT AT03794267T patent/ATE414904T1/de not_active IP Right Cessation
- 2003-09-05 WO PCT/JP2003/011388 patent/WO2004023141A1/ja not_active Ceased
- 2003-09-05 US US10/526,494 patent/US7455976B2/en not_active Expired - Fee Related
- 2003-09-05 EP EP03794267A patent/EP1548436B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE60324820D1 (de) | 2009-01-02 |
| US7455976B2 (en) | 2008-11-25 |
| WO2004023141A1 (ja) | 2004-03-18 |
| JPWO2004023141A1 (ja) | 2005-12-22 |
| US20060099644A1 (en) | 2006-05-11 |
| EP1548436B1 (de) | 2008-11-19 |
| AU2003261976A1 (en) | 2004-03-29 |
| EP1548436A4 (de) | 2006-09-20 |
| JP4280236B2 (ja) | 2009-06-17 |
| EP1548436A1 (de) | 2005-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE433108T1 (de) | Radiomarkierungssatz und bindungstest | |
| DE602005008848D1 (de) | Verfahren und tragbarer Apparat zur Messung des Kalorieverbrauchs. | |
| DE69730123D1 (de) | Bewertungsmethode für wegwerfbare absorbierende Artikel | |
| DE69430231D1 (de) | Biosensor zum Messen der Alkoholkonzentration, Verfahren zur Herstellung des Biosensors, und den Biosensor benutzendes Betrunkenheitsmessgerät | |
| ATE421092T1 (de) | Verwendung von gfap zum nachweis von intrazerebraler blutung | |
| ATE534038T1 (de) | Neurodegenerative marker für alzheimer-krankheit | |
| WO2005031005A3 (en) | Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample | |
| WO2004094675A3 (en) | Compositions and methods for determining the presence of sars coronavirus in a sample | |
| DE602005020446D1 (de) | Konfokale flüssigkeitsstandmessung | |
| WO2004040252A3 (en) | Molecules and methods using same for measuring non-transferrin bound iron | |
| ATE443775T1 (de) | Hif-prolylhydroxylase-aktivitätstest | |
| DE60328055D1 (de) | Verfahren zum nachweis von pathogenen mykobakterien in klinischen proben | |
| ATE414904T1 (de) | Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo | |
| WO2005124356A3 (en) | Use of protein cbp2 as a marker for colorectal cancer | |
| ATE277352T1 (de) | Einetenascin-c isoform als marker für neoplasmen | |
| IL135884A (en) | Method for measuring non-transferrin bound iron | |
| EP1541992A4 (de) | Messinstrument für nichtlineare komplexe empfindlichkeit mit zeitauflösung | |
| ATE540048T1 (de) | Neurotransmittersensoren und verfahren zu ihrer verwendung | |
| WO2006066917A3 (en) | Use of asc as a marker for colorectal cancer | |
| DE602005023784D1 (de) | Blockierter enzymsondenkomplex | |
| AU2007332452B2 (en) | Method for measuring 1,5-anhydroglucitol in whole blood, and sensor chip and measurement kit to be used in the method | |
| ATE403141T1 (de) | Verfahren und vorrichtung zur messung rheologischer stoffeigenschaften einer visko- elastischen probe. | |
| FI20035158A0 (fi) | Mittausmenetelmä/laite kaasupitoisuuden mittaamiseen nesteistä | |
| WO2005124362A3 (de) | Verfahren und testkit zur diagnose einer ischämischen herzschädigung, insbesondere der latenten chronischen formen, durch serologischen nachweis der myosin lechtkette-1 | |
| WO2005040807A3 (en) | Swiprosin-2 as a breast cancer marker |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |